Integra LifeSciences Holdings Corporation

IL3.F·Frankfurt
Compare
11.800.00 (0.00%)today
As of Oct 21, 8:03 AM CEST · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close11.80
Open11.80
Day range—
52-week range7.6017.30
Off day high0.00%
Off 52-week high−31.79%
Volume100
Avg. volume (3M)3.00
Market cap917.72M
EPS (TTM)-0.0800
Forward P/E3.45
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding77.77M
Short interest—
Earnings dateOct 21, 2026
Analyst target—
Profit margin—

Latest news

All IL3.F news ›
Stock Titan·

Integra LifeSciences: Caruso holds 43,590 shares

Options carry exercise prices from $23.95 to $68.10 and expire in 2028–2033. Each award becomes exercisable in 25% increments over four anniversaries. - [Form 3] INTEGRA LIFESCIENCES HOLDINGS CORP Initial Statement of Beneficial Ownership…

Seeking Alpha·

Integra LifeSciences prices $450M in 9.5% secured notes

Integra LifeSciences (IART) prices $450M 9.5% senior secured notes due 2033 to refinance credit facilities. - Integra LifeSciences (IART) said it priced $450M in 9.5% senior secured notes due 2033, with the offering expected to close…

Stock Titan·

Integra LifeSciences cuts 2026 adjusted EPS to $2.30–$2.40

Btab Defines Its Vision as a Generational Project for the AI Era Integra expects the Cincinnati facility to return to full manufacturing operations in the second quarter of 2027. Full manufacturing operations at Cincinnati are expected to…

From articles in the 4Search news index.

In the news

30mentions in 30 days
30with it in the headline
Negativesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 30 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.